Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002387715 | SCV002691903 | pathogenic | Hereditary cancer-predisposing syndrome | 2021-04-23 | criteria provided, single submitter | clinical testing | The c.1341_1343delCTCins17 pathogenic mutation, located in coding exon 8 of the MSH2 gene, results from the deletion of 3 nucleotides and insertion of 17 nucleotides causing a translational frameshift with a predicted alternate stop codon (p.S448Qfs*24). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |